InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Browse the complete record of transactions filed by Congleton Jon, Chief Executive Officer. Insider active across 1 companies, notably Mineralys Therapeutics, Inc.. In total, 8 reports have been recorded. Total volume traded: €3.1m. The latest transaction was filed on 13 April 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
US$358,55615,730 shares@ US$22.79440.016% mcap23.3% of flow
Common Stock
SEC:0001933414-26-000075·
€358,55615,730 shares@ €22.79440.016% mcap11.7% of flow
Common Stock
SEC:0001933414-26-000075:0·
US$426,63319,364 shares@ US$22.03230.019% mcap27.8% of flow
Common Stock
SEC:0001644975-26-000004·
€426,63319,364 shares@ €22.03230.019% mcap13.9% of flow
Common Stock
SEC:0001644975-26-000004:0·
US$252,6809,119 shares@ US$27.70910.011% mcap16.4% of flow
Common Stock
SEC:0001644975-26-000002·
€252,6809,119 shares@ €27.70910.011% mcap8.2% of flow
Common Stock
SEC:0001644975-26-000002:0·
€499,31013,548 shares@ €36.85490.022% mcap16.2% of flow
Common Stock
SEC:0001933414-25-000129:0·
US$499,31013,548 shares@ US$36.85490.022% mcap32.5% of flow
Common Stock
SEC:0001933414-25-000129·
8 of 8 declarations
About Congleton Jon
Congleton Jon is the Chief Executive Officer of Mineralys Therapeutics, Inc. He leads the company in the biotechnology sector, focusing on developing innovative treatments. His role is essential in guiding Mineralys towards innovation and growth in the healthcare field.
